dr. weiss on pd-l1 biomarker in lung cancer
Published 7 years ago • 204 plays • Length 2:24Download video MP4
Download video MP3
Similar videos
-
1:41
dr. goldberg on pd-l1 as a biomarker in lung cancer
-
1:36
dr. weiss on disease-control rate of immunotherapy for lung cancer
-
4:47
pd-l1 biomarker testing
-
1:24
dr. lilenbaum on pd-l1 as a predictive biomarker for immunotherapy in lung cancer
-
2:07
dr. weiss on biomarkers in head and neck cancer
-
1:21
dr. kim discusses pd-l1 as a biomarker in lung cancer
-
1:22
dr. weiss on immunotherapy combinations in head and neck cancer
-
1:42
dr. gandara discusses pd-l1 as a biomarker in lung cancer
-
10:20
pd-l1 testing in advanced lung cancer
-
7:34
pd-l1 as a biomarker in squamous non-small cell lung cancer
-
1:03
dr. barbara j. gitlitz on why pd-l1 is not a good biomarker for immunotherapy in lung cancer
-
2:11
dr. weiss on next steps for immunotherapy in head and neck cancer
-
1:00
dr. mason on the reliability of the pd-l1 biomarker
-
5:02
dr blythe adamson: pd-l1 as a predictive biomarker in lung cancer continues to evolve
-
2:13
the value of pd-l1 as a biomarker beyond lung cancers
-
0:49
dr. weiss on developments in the treatment of head and neck cancer
-
9:54
is the pd-l1 biomarker ready for prime time?
-
1:00
dr. nadler discusses role of pd-l1 in squamous nsclc
-
1:13
guiding nsclc treatment with biomarkers